Overview of pulsed electric field (pef) preservation on food products

The rise in consumer demand for nutritious food options combined with a desire for a more natural taste has prompted the creation of novel gentle food preservation processes as alternatives to traditional methods like heat treatment. New Methods like high hydrostatic pressure and pulsed electric fields (PEFs), have emerged as no thermal pasteurization methods. These methods aim to effectively reduce microbial content while maintaining the quality of the food product. Pulsed electric field processing is particularly suitable for decontaminating heat-sensitive foods. Furthermore, it presents no environmental risks and has shown no indications of toxicity [1]

Spirulina: nutritional and therapeutic review

The current environmental conditions deteriorations, mental and physical stress, changes in the diet have been serious risk factors for the humans, increased the death rate and civilization diseases. These are the obvious reasons why new progressive trends are being extensively developed in modern medicine, pharmacology and biotechnology and more effective harmless medicaments are being sought for to treat and prevent various diseases. One of the trends in biotechnology is associated with Blue green microalgae Spirulina platensis which have been widely employed as food and feed additives in agriculture, food industry, pharmaceuticals, perfume making, medicine and science [1]

Performance Testing and Analysis of Synchronous Reluctance Motor Utilizing Dual-phase Magnetic Material

While interior permanent magnet (1PM) machines have been considered the state-of-the art for traction motors, synchronous reluctance (SynRel) motors with advanced materials can provide a competitive alternative. 1PM machines typically utilize Neodymium 1ron Boron (NdFeB) permanent magnets, which pose an issue in terms of price, sustainability, demagnetization at higher operating temperatures, and uncontrolled generation. On the other hand, SynRel machines do not contain any magnets and are free from these issues. However, the absence of magnets as well the presence of bridges and centerposts limit the flux-weakening capability of a SynRel machine and limit the achievable constant power speed ratio (CPSR) without having to significantly oversize the machine and/or the power converter. 1n this paper, a new material referred to as the dual-phase magnetic material where nonmagnetic regions can be selectively introduced within each lamination will be evaluated for SynRel designs. The dual-phase feature of this material enables non-magnetic bridges and posts, eliminating one of the key limitations of the SynRel designs in terms of torque density and flux-weakening. This paper will present, the design, analysis and test results of an advanced proof-of-concept SynRel design utilizing dual-phase material with traction applications as the ultimate target application

Finding Universal Inhibitor of Amyloid Aggregation

Protein misfolding and aggregation results in many human diseases and some diseases are caused when protein aggregation leads to amyloid formation(Chiti and Dobson, 2006). Amyloids are rigid, insoluble, unbranched, fibrous and well organized proteinaceous materials having cross-β core structure(Chiti and Dobson, 2006)(Nelson et al., 2005). They have characteristic “cross β-sheet” structure, revealed by X-ray diffraction studies. Detection of amyloid can be done by both congo red binding and thioflavin-T (Th-T) assay. Thermodynamic properties of complexes of Congo Red (CR) dye with amyloid β(Aβ) peptides were studied by absorption spectroscopy and thioflavin-T were studied by fluorescence spectroscopy. Inhibition of pathogenic protein aggregation may be an important and straight forward therapeutic strategy for curing amyloid diseases.inhibitory effect of 3-aminophenol, GPS-1, GPS-2 on bovine serum albumin, lysozyme, rnq1 prion protein amyloid aggregates were studied. 3aminophenol shows significant inhibitory action on lysozyme amyloid aggregates

Improving Power Quality with Non-Segregated Dynamic Voltage Restorer-Ultra capacitor Design

A product that might improve voltage sag and swell change and integration of energy storage is the dynamic voltage restorer (DVR). Ultra capacitors, or UCAPs, are conducive in relieve voltage swells and sags which compose a challenge to high power for concise periods of time. In the end, both high power density and low energy density are consummate. One vital outcome of the ongoing study is that the DVR form accommodate rechargeable UCAP-based energy storage. When this system is assimilate, it will banish commitment for the grid to monitor for foible on the grid as long as the UCAPDVR system wield as an active power source and self-adjust to indemnify for unforeseen voltage swells and sags. An engrossing way to lessen sag is to utilize a dual-way DC-DC converter connected to an ultra-capacitor or dynamic voltage restorer to provide an accurate dc-link output voltage for the DVR. As a result of the integrated UCAP- DVR's advancement, speedy harmonic distortion is mitigated by reducing transient voltage swells and sags simultaneously. The PI controller will be leaned over other controllers in this specimen. A suggested framework is confirmed by virtue of, simulations using MATLAB/Simulink software

Trace-gas metabolic versatility of the facultative methanotroph Methylocella silvestris

The climate-active gas methane is generated both by biological processes and by thermogenic decomposition of fossil organic material, which forms methane and short-chain alkanes, principally ethane, propane and butane1, 2. In addition to natural sources, environments are exposed to anthropogenic inputs of all these gases from oil and gas extraction and distribution. The gases provide carbon and/or energy for a diverse range of microorganisms that can metabolize them in both anoxic3 and oxic zones. Aerobic methanotrophs, which can assimilate methane, have been considered to be entirely distinct from utilizers of short-chain alkanes, and studies of environments exposed to mixtures of methane and multi-carbon alkanes have assumed that disparate groups of microorganisms are responsible for the metabolism of these gases. Here we describe the mechanism by which a single bacterial strain, Methylocella silvestris, can use methane or propane as a carbon and energy source, documenting a methanotroph that can utilize a short-chain alkane as an alternative to methane. Furthermore, during growth on a mixture of these gases, efficient consumption of both gases occurred at the same time. Two soluble di-iron centre monooxygenase (SDIMO) gene clusters were identified and were found to be differentially expressed during bacterial growth on these gases, although both were required for efficient propane utilization. This report of a methanotroph expressing an additional SDIMO that seems to be uniquely involved in short-chain alkane metabolism suggests that such metabolic flexibility may be important in many environments where methane and short-chain alkanes co-occur

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary

Treatment options are currently limited for persons with HIV-1 (PWH) who are heavily treatment-experienced and/or have multidrug-resistant HIV-1. Three agents have been approved by the U.S. Food and Drug Administration (FDA) since 2018, representing a significant advancement for this population: ibalizumab, fostemsavir, and lenacapavir. However, there is a paucity of recommendations endorsed by national and international guidelines describing the optimal use (e.g., selection and monitoring after initiation) of these novel antiretrovirals in this population. To address this gap, a modified Delphi technique was used to develop these consensus recommendations that establish a framework for initiating and managing ibalizumab, fostemsavir, or lenacapavir in PWH who are heavily treatment-experienced and/or have multidrug-resistant HIV-1. In addition, future areas of research are also identified and discussed in the main document

An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.

BACKGROUND:There has been widespread interest in the potential of combination cardiovascular medications containing aspirin and agents to lower blood pressure and cholesterol ('polypills') to reduce cardiovascular disease. However, no reliable placebo-controlled data are available on both efficacy and tolerability. METHODS:We conducted a randomised, double-blind placebo-controlled trial of a polypill (containing aspirin 75 mg, lisinopril 10 mg, hydrochlorothiazide 12.5 mg and simvastatin 20 mg) in 378 individuals without an indication for any component of the polypill, but who had an estimated 5-year cardiovascular disease risk over 7.5%. The primary outcomes were systolic blood pressure (SBP), LDL-cholesterol and tolerability (proportion discontinued randomised therapy) at 12 weeks follow-up. FINDINGS:At baseline, mean BP was 134/81 mmHg and mean LDL-cholesterol was 3.7 mmol/L. Over 12 weeks, polypill treatment reduced SBP by 9.9 (95% CI: 7.7 to 12.1) mmHg and LDL-cholesterol by 0.8 (95% CI 0.6 to 0.9) mmol/L. The discontinuation rates in the polypill group compared to placebo were 23% vs 18% (RR 1.33, 95% CI 0.89 to 2.00, p = 0.2). There was an excess of side effects known to the component medicines (58% vs 42%, p = 0.001), which was mostly apparent within a few weeks, and usually did not warrant cessation of trial treatment. CONCLUSIONS:This polypill achieved sizeable reductions in SBP and LDL-cholesterol but caused side effects in about 1 in 6 people. The halving in predicted cardiovascular risk is moderately lower than previous estimates and the side effect rate is moderately higher. Nonetheless, substantial net benefits would be expected among patients at high risk. TRIAL REGISTRATION:Australian New Zealand Clinical Trials Registry ACTRN12607000099426

Analysis of changing statistical significance from .05 to .005 in foot and ankle randomized controlled trials

Background: Misinterpretation of p-values in RCTs is extremely problematic since they are the core basis for high levels of recommendation in clinical practice guidelines, especially Orthopaedics. Benjamin et al. proposed a universal protocol change, moving statistical significance from a p-value of .05 to .005 to combat the misinterpretation that is happening in medical literature. In this study, we are looking to evaluate the effect of the protocol suggested by Benjamin et al. on foot and ankle-related RCTs in the top 3 Foot and Ankle-related journals.Methods: We conducted a Pubmed search looking at studies published from January 1st, 2016 to November 10, 2021, in the following three journals; Foot and Ankle International, Journal of Foot and Ankle Surgery, and Foot & Ankle International. The inclusion criteria for the study were RCTs published in the above journals with specifically stated primary endpoints. If a study has multiple primary endpoints, all were included. Exclusion criteria were any study that was not prospective and randomized by design, also any study that did not state primary endpoints was excluded. Two authors extracted the data using a pilot-tested Google form, any disagreements or questions were resolved by published methodologic orthopaedic authors.Results: Of the 222 endpoints, 101 endpoints (45.5%; 101/222) were at or below the .05 threshold while 121 endpoints (54.5%; 121/222) were above the .05 threshold. We also found that 59 endpoints (26.6%; 59/222) were below .005.Conclusion: Our results suggest that changing the threshold for statistical significance from .05 to .005 in foot and ankle RCTs would heavily alter literature published in the field. By implementing this methodology, it is a promising measure to be able to increase RCT quality until a more substantial solution can be found. With that being said, caution must be taken when interpreting our results, also requiring further evaluation

IL-33 Mediates Pseudomonas Induced Airway Fibrogenesis and Is Associated with CLAD

BACKGROUND: Long term outcomes of lung transplantation are impacted by the occurrence of chronic lung allograft dysfunction (CLAD). Recent evidence suggests a role for the lung microbiome in the occurrence of CLAD, but the exact mechanisms are not well defined. We hypothesize that the lung microbiome inhibits epithelial autophagic clearance of pro-fibrotic proteins in an IL-33 dependent manner, thereby augmenting fibrogenesis and risk for CLAD. METHODS: Autopsy derived CLAD and non-CLAD lungs were collected. IL-33, P62 and LC3 immunofluorescence was performed and assessed using confocal microscopy. Pseudomonas aeruginosa (PsA), Streptococcus Pneumoniae (SP), Prevotella Melaninogenica (PM), recombinant IL-33 or PsA-lipopolysaccharide was co-cultured with primary human bronchial epithelial cells (PBEC) and lung fibroblasts in the presence or absence of IL-33 blockade. Western blot analysis and quantitative reverse transcription (qRT) PCR was performed to evaluate IL-33 expression, autophagy, cytokines and fibroblast differentiation markers. These experiments were repeated after siRNA silencing and upregulation (plasmid vector) of Beclin-1. RESULTS: Human CLAD lungs demonstrated markedly increased expression of IL-33 and reduced basal autophagy compared to non-CLAD lungs. Exposure of co-cultured PBECs to PsA, SP induced IL-33, and inhibited PBEC autophagy, while PM elicited no significant response. Further, PsA exposure increased myofibroblast differentiation and collagen formation. IL-33 blockade in these co-cultures recovered Beclin-1, cellular autophagy and attenuated myofibroblast activation in a Beclin-1 dependent manner. CONCLUSION: CLAD is associated with increased airway IL-33 expression and reduced basal autophagy. PsA induces a fibrogenic response by inhibiting airway epithelial autophagy in an IL-33 dependent manner